Idorsia Ltd
SIX:IDIA.SW
Overview | Financials
Company Name | Idorsia Ltd |
Symbol | IDIA.SW |
Currency | CHF |
Price | 0.923 |
Market Cap | 166,282,931 |
Dividend Yield | 0% |
52-week-range | 0.89 - 3.7 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jean-Paul Clozel M.D. |
Website | https://www.idorsia.com |
An error occurred while fetching data.
About Idorsia Ltd
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD